Indicators for tracking the effect of the economic crisis on pharmaceutical consumption - PowerPoint PPT Presentation

Loading...

PPT – Indicators for tracking the effect of the economic crisis on pharmaceutical consumption PowerPoint presentation | free to download - id: 718023-YzQ2N



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Indicators for tracking the effect of the economic crisis on pharmaceutical consumption

Description:

Indicators for tracking the effect of the economic crisis on pharmaceutical consumption The Asian Financial Crisis in 1997/8 demonstrates the potential impact on ... – PowerPoint PPT presentation

Number of Views:23
Avg rating:3.0/5.0
Slides: 7
Provided by: Steph407
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Indicators for tracking the effect of the economic crisis on pharmaceutical consumption


1
Indicators for tracking the effect of the
economic crisis on pharmaceutical consumption
2
The Asian Financial Crisis in 1997/8 demonstrates
the potential impact on access to medicines
,
Real GDP (LCU) (Q2 971)
Drug Consumption (SU) (Q2 971)
1.4
1.4
1.3
1.3
Korea
1.2
1.2
1.1
Thailand
1.1
Thailand
Indonesia
Indonesia
1.0
1.0
0.9
Korea
0.9
0.8
0.0
0.0
of Quarters Q0 Q2 97
of Quarters Q0 Q2 97
Source ????
Source IMS Midas
3
The WHO, in collaboration with IMS, has
established a programme to monitor the current
impact
  • 83 countries, approximately 81 of global
    population, quarterly reports
  • Impact on expenditure (Leading indicators)
  • Total expenditure
  • Average price per unit of volume
  • Impact on consumption (Lagging indicator)
  • Total volume
  • Volume of acute and chronic medicines
  • Movement to or from original and licensed branded
    medicines

4
Earliest indicators suggest first signs of
economic impact
Note Canada, Puerto Rica, USA, Uruguay (Public)
Netherlands, Australia and New Zealand have all
had price declines in at least three quarters
since start of 2008 until end of Q1 2009 when
compared to the same quarter a year previously.
5
Volume indicators also beginning to show signs of
worsening
6
Conclusions
  • No firm evidence of a negative impact except
    perhaps in Estonia and the private sector in
    Russia
  • So far countries seem to have absorbed the
    moderate price increases without a loss in
    medicine consumption
  • Confident that the data collection methods and
    the analytic tools available will enable us to
    detect significant changes as soon as they occur
  • When such changes are detected, governments have
    a range of policy instruments to alleviate the
    situation
About PowerShow.com